An expression system for analysis of the synthesis and processing of the E2 glycoprotein of a hepatitis C virus (HCV) genotype 1a strain was developed in transiently transfected cells. E2 proteins representing the entire length of the protein, including the transmembrane segment (E2) as well as two truncated versions (E2 660 and E2 715 ), were characterized for acquisition of N-linked glycans and transport to the media of transfected cells. To investigate the utilization of the 10 potential N-linked glycosylation sites on this E2 protein, a series of mutations consisting of single or multiple (two, three, four or eight) ablations of asparagine residues in the background of the E2 660 construct were analyzed. E2 660 proteins harboring single or multiple site mutations were produced at levels similar to that of wild-type protein, but secretion of the single mutants was mildly diminished, and elimination of two or more sites dramatically reduced delivery of the protein to the media. Similar results were obtained in Huh-7 cells with respect to intracellular synthesis and secretion of the mutant proteins. Analysis of oligosaccharide composition using endoglycosidase digestion revealed that all of the glycan residues on the intracellular forms of E2 660 , E2 715 , and E2 contained N-linked glycans modified into high-mannose carbohydrates, in contrast to the secreted forms, which were endo H resistant. The parental E2 660 protein could be readily detected in Huh-7 cells using anti-polyhistidine or antibody to recombinant E2. In contrast, E2 660 lacking the eight N-linked glycans was expressed but not detectable with anti-E2 antibody, and proteins lacking four glycans exhibited reduced reactivity. These experiments provide direct evidence that the presence of multiple N-linked glycans is required for the proper folding of the E2 protein in the ER and secretory pathway as well as for formation of its antigenic structure. D
Introduction
Hepatitis C virus (HCV) encodes two envelope glycoproteins, E1 and E2, which form the major antigenic components of the virion (Houghton, 2003) . These proteins contain many important biological activities, including neutralizing antibody epitopes and binding determinants for CD81, LDLr, and possibly other putative cellular receptors involved in virus entry (Agnello et al., 1999; Flint et al., 1999a; Gardner et al., 2003; Monazahian et al., 1999; Pileri et al., 1998; Scarselli et al., 2002; Wunschmann et al., 2000) . E1 is a 31-kDa protein containing six potential Nlinked glycans, whereas E2 is an approximately 65 -70-kDa protein, with as many as 11 potential N-linked sites (Dubuisson et al., 1994; Op De Beeck et al., 2001 ). E1 and E2 are cotranslationally synthesized and processed in association with the endoplasmic reticulum of host cells and form two different types of complexes within the cell. Covalent interactions involving interchain disulfide bonds are believed to result in the formation of aggregated E1 -E2 complexes which are probably targeted for degradation, although their role in HCV pathogenesis remains unknown (Dubuisson, 2000; Liberman et al., 1999) . Noncovalently associated E1 -E2 complexes generated from properly folded forms of these proteins are presumed to represent prebudding structures that are ultimately incorporated into mature virions (Deleersnyder et al., 1997; Ralston et al., 1993; reviewed in Op De Beeck et al., 2001) . Production of the native complexes based on transient expression experi-ments in mammalian cells requires a prolonged time of formation compared to the folding and maturation of other viral membrane glycoproteins (Doms et al., 1993; Dubuisson et al., 1994) . Formation of these native and aggregated complexes is a complicated process involving interactions with calnexin, calreticulin, Bip, and perhaps other ER chaperones (Choukhi et al., 1998; Dubuisson and Rice, 1996) , as well as protein disulfide isomerase and peptidylprolyl isomerases, which are implicated in early folding events of proteins (Ellgaard and Helenius, 2003; Parodi, 2000) . The E1 and E2 proteins are retained in the ER by retention signals in their transmembrane domains, suggesting that these regions are necessary for incorporation of the proteins into the virion envelope within an intracellular membrane compartment (Cocquerel et al., 1999 (Cocquerel et al., , 2000 Duvet et al., 1998) . The exact location of virion assembly and the precise modifications of E1 and E2, which are required for this process, remain incompletely understood. E1 and E2 proteins and virus-like particles have been localized in association with intracellular membranes at the level of the ER (Baumert et al., 1998; Dubuisson et al., 1994; Martire et al., 2001) . Transmembrane regions are involved in the folding of E1, and E1 -E2 complex formation Op De Beeck and Dubuisson, 2003; Patel et al., 2001) , and some studies have shown that the ectodomains of E1 and E2 participate in this process as well (Patel et al., 2000; Yi et al., 1997) . Precise molecular determinants for many of these events and their importance for the function and antigenicity of the E1 -E2 complex have been partially characterized (reviewed in Op De Beeck and Dubuisson, 2003; Op De Beeck et al., 2001) .
The E2 glycoprotein encodes as many as 11 N-linked glycosylation sites, with previous studies suggesting that many or all of these sites are utilized during posttranslational processing of nascent E1 -E2 complexes (Dubuisson et al., 1994; Lanford et al., 1993; Matsuura et al., 1994; Spaete et al., 1992) . N-linked oligosaccharide addition is a common step in the maturation of viral envelope glycoproteins and is often necessary for proper folding of such proteins, either through effects on solubility, stability, or by facilitating interactions with lectinbinding chaperones that participate in folding of proteins within the ER lumen (Doms et al., 1993) . In some cases, the precise position of an N-linked glycan is critical for the proper folding of the viral protein, and elimination of even a single site can abrogate normal processing (Helenius, 1994 ). In the case of some viral proteins with multiple N-linked sites such as the influenza hemagglutinin and the simian virus 5 hemagglutinin/neuraminidae, individual N-linked glycans can mediate important effects on folding, oligomerization, transport, and aggregation when analyzed with appropriate assays (Ng et al., 1990; Roberts et al., 1993) . In other cases, less dominant effects have been observed (Gallagher et al., 1992) . In addition to assisting in the folding of antigenically complex proteins, it is conceivable that multiple N-linked glycans may have In panels C and D, cells were transfected, 35 [S]-methionine labeled proteins were immunoprecipitated and analyzed on 12% SDS polyacrylamide gels as described in the Materials and methods. MWs (kDa) were determined with radioactive markers.
other functions, such as masking proteins from reactivity with virus-specific antibodies, facilitating escape from neutralization by antibodies, or complement, and interfering with antigen processing. The observation that antigenicity of viral glycoproteins can in some cases be enhanced by elimination of N-linked glycosylation sites is consistent with these hypotheses (Fournillier et al., 2001; Mori et al., 2001) .
To gain further insight into the importance of N-linked glycosylation of E2 for its synthesis and processing, we constructed a series of mutants in which single or multiple N-linked sites were abolished by site-directed mutagenesis in the context of a truncated protein (E2 660 ) containing the first 276 amino acids of the E2 region. These mutants were characterized by transient expression in cell culture to determine which potential sites are utilized, and how the synthesis and transport of E2 proteins lacking oligosaccharides are affected in this system. Although E2 660 is not representative of the form of E2 incorporated into native E1 -E2 complexes (Clayton et al., 2002; Op De Beeck et al., 2001) , its ability to traverse the secretory pathway and be modified into higher MW secreted forms (Michalak et al., 1997) suggests that glycosylation events which accompany this process reflect their importance for formation of a correctly folded protein (Ellgaard and Helenius, 2003) . Results of our study indicate that proper expression of the E2 protein in this system is dependent on the presence of at least eight N-linked glycans, each of which contributes to some extent to the processing and maturation of a secreted form of the protein and integrity of its antigenic properties.
Results

Construction and properties of the E2 expression system
In initial experiments, an RT -PCR-derived clone of the E1 -E2 region of an HCV genotype 1a strain was used to establish requirements for expression of the E2 protein. The amino acid sequence of the genotype 1a E2 clone was highly homologous with the H and BK strains (79% and 84%, respectively). This clone contained 10 potential Nlinked glycosylation sites. Expression of this E2 protein was examined by constructing various pcDNA3.1-based plasmids encoding the E2 region with an amino-terminal signal sequence derived from the E1 region and with different carboxy termini (Fig. 1A) . The carboxy termini were positioned at amino acid 660, 715, or 746 of the HCV open reading frame, corresponding to residues 276, 331, or 362 of the E2 open reading frame, respectively. These positions were based on previous studies of others which showed that a truncated E2 661 protein was able to traverse the secretory pathway and undergo proper folding more efficiently than longer forms (Flint et al., 1999b (Flint et al., , 2000 Matsuura et al., 1994; Michalak et al., 1997; Spaete et al., 1992) .
In cell-free translation experiments in the presence of microsomal membranes, the E2 715 protein was synthesized and underwent apparent signal peptide cleavage and core glycosylation, indicating that the initial stages of entry into the secretory pathway were properly achieved by this protein (Fig. 1B) . Similar results were obtained with the E2 660 protein (data not shown). Core glycosylation resulted in an increase in the apparent MW of the E2 715 protein of approximately 68 kDa, consistent with modification by as many as 11 asparagine-linked oligosaccharides, as predicted by the primary sequences of various HCV strains (Roggendorf et al., 1993) . Fig. 1C illustrates the expression of the engineered E2 proteins in BHK cells. E2 715 and E2 660 constructs produced proteins of MWs 62 and 56 kDa, respectively, whereas the E2 construct produced a protein of MW 60 kDa. This appeared smaller in MW than E2 715 perhaps because of anomalous migration caused by the hydrophobic carboxyl-terminus contributed by the TM region. The E2 715 and E2 660 constructs also produced secreted forms of E2 which were recoverable from the media as diffusely migrating proteins exhibiting MWs of 74 and 65 kDa, respectively, whereas E2 was not secreted. The amount of E2 715 recovered was very low compared to that of E2 660 . These results are consistent with the E2 660 and E2 715 proteins lacking the ER retention signal characteristic of the E2 protein as previously described by Michalak et al. (1997) . E2 proteins lacking an N-terminal signal sequence were poorly expressed in our system (data not shown). E2 proteins from cells labeled in the presence of tunicamycin (Panel D) revealed that the MWs of the E2 715 and E2 660 proteins were reduced to approximately 39 and 34 kDa, respectively, consistent with what is predicted for the corresponding regions of the E2 open reading frames attached to the c-myc and polyhistidine tags. The E2 protein migrated as two bands of MWs 38 and 35 kDa, respectively, less than the predicted size of 43 kDa, presumably because of aberrant migration or partial degradation of the unglycosylated form. Tunicamycin treatment abolished secretion of the E2 715 and E2 660 proteins into the media.
To further characterize E2 proteins, intracellular and secreted forms of the proteins were subjected to digestion with endoglycosidase F or H (Fig. 2) . For the parental cellassociated E2 660 protein, treatment with these enzymes reduced the MW to 36 and 37 kDa, respectively, and intermediate digestion products were observed in the case of endo F digestion (Fig. 2, top panel) . For the E2 715 protein, a similar effect was observed with the endo Fand endo H-treated forms migrating with apparent MWs of 42 and 43 kDa. For the E2 protein, the endo F and endo H digestion products migrated with MWs of 41 and 42 kDa. Analysis of the carbohydrates present on the secreted form of the E2 660 protein was also undertaken (Fig. 2, lower  panel) . Comparison of the intracellular and secreted forms of E2 660 revealed that the latter was resistant to endoglycosidase H digestion, consistent with the acquisition of complex-type carbohydrates upon maturation through the secretory compartment. E2 715 was secreted into the media in low levels, and characterization of endoglycosidase H resistance on this form was inconclusive. Collectively, these data indicate that the E2 protein expressed in this system resembles that of other systems which have characterized this protein (Dubuisson et al., 1994; Lanford et al., 1993; Lucas et al., 2003; Matsuura et al., 1994; Ralston et al., 1993; Tsitoura et al., 2002) . The presence of c-myc/polyhistidine tags used for detection of E2 did not seem to adversely affect its properties.
Analysis of N-linked glycosylation site mutants
To determine which of the 10 predicted N-linked glycosylation sites were used for modification of the E2 660 protein, a series of mutations were engineered at each Nlinked site individually and in various combinations (Fig. 3 ). For each mutation, the serine or threonine residue of the N -X -T acceptor site was modified by replacement with an alanine residue. The E2 660 construct was initially used for analysis of the effects of these mutations because the synthesis and secretion of this protein were more efficient than that of E2 715 , and others have reported that this form of E2 attains a conformation that is consistent with a properly folded protein (Michalak et al., 1997) .
Analysis of E2 660 proteins containing single mutations at the N-linked glycosylation sites revealed that each of the first eight predicted sites (N1 through N8) was utilized for the addition of carbohydrate when analyzed by transient expression in BHK cells (Figs. 4A and B, top panels). This conclusion is because each of the mutants N1 -N8 exhibited a small decrease in MW of approximately 2 kDa, consistent with the loss of a single N-linked oligosaccharide. However, mutants N9 and N10 did not appear to undergo this decrease in MW, suggesting that these sites were not utilized in this protein. Introduction of the single mutations also did not adversely affect the levels of expression of the cell-associated E2 660 proteins, as judged by the generally similar levels of the proteins detected in this assay. Each E2 660 protein containing a single mutation produced slightly less of the soluble form of E2 660 in the media compared to that of the parental protein, except for mutants N9 and N10 (Figs. 4A and B, bottom panels) . This suggests that elimination of even a single N-linked glycan causes a mild impairment in the transport of E2 660 through the secretory pathway.
We next examined the effects of combining mutations at different N-linked sites on the expression and processing of E2 660 , as shown in Fig. 5 (top panel) . All proteins containing two or three mutations (N1 + N2 + N3; N5 + N6; N7 + N8, N1 + N2 [see Fig. 7 below] , or N1 + N3 [data not shown]) were readily detectable, but the apparent MWs of these mutant proteins were reduced in proportion to the number of N-linked sites eliminated (approximately 4 kDa for loss of two sites, and 6 kDa for loss of three sites). Production of the soluble extracellular forms of these mutant proteins was markedly reduced (Fig. 5, top panel) . A further series of mutant proteins containing ablation of four (N1-4 or N5-8) or eight (N1-8) of the N-linked glycans were next analyzed. Mutant E2 660 proteins lacking four sites (N1-4 or N5-8) exhibited reductions in apparent MWs to 48 kDa, consistent with the loss of four N-linked glycans. The mutant E2 660 protein lacking all eight N-linked sites (N1-8) was readily detectable and migrated with an apparent MW of 36 kDa, consistent with the results of tunicamycin treatment and endoglycosidase digestions (Figs. 1 and 2) . None of the mutant proteins lacking four or more N-linked glycans was recovered from the media. These data suggest that loss of four or more of the glycans is very deleterious for transport of the E2 660 protein through the secretory pathway.
Expression in Huh-7 cells
To determine if utilization of the N-linked sites on E2 660 is influenced by the cell type used for expression, the mutants were also analyzed in Huh-7 cells. These cells were chosen to more accurately reflect the processing of E2 proteins in a hepatic cellular environment. Results of these experiments are shown in Fig. 6 . Similar to the results in BHK cells, the single glycosylation mutants N1 through N8 migrated with apparent MWs consistent with the loss of one N-linked glycan (Fig. 6 , top and middle panels). As observed in BHK cells, mutants N9 and N10 appeared to comigrate with the parental E2 660 protein (Fig. 6 , middle panel), suggesting that these sites are not utilized in Huh-7 cells. Mutants N1-3, N1-4, N5-8, and N1-8 also exhibited MW differences from E2 660 which were similar to those observed in BHK cells (Fig. 6, bottom panel) . In the case of Huh-7 cells, multiple additional bands were observed for the parental and mutant forms of E2 660 . Although some of these represented proteins from mock-infected cells, the lower molecular weight forms may represent partially glycosylated proteins, or even the unglycosylated 36-kDa E2 polypeptide. These observations suggest that glycosylation of E2 in Huh-7 cells may be less efficient than BHK cells. The secretion of the E2 660 protein and the N-linked mutants in Huh-7 cells were also generally similar to what was observed in BHK cells (data not shown). Taken together, these results suggest that modification of the E2 660 protein by N-linked glycosylation occurs in a similar manner in both BHK and Huh-7 cells. The results of expression experiments for BHK and Huh-7 cells are summarized in Table 1 .
Analysis of N-linked sites 9 and 10
Because expression of E2 660 proteins containing single mutations at sites N9 and N10 indicated that these sites were not utilized (Figs. 3B and 5 ), studies were then done to determine if utilization occurred in the context of the longer proteins E2 715 or E2. Fig. 7 shows the results of these experiments. When compared to their parental proteins, E2 715 and E2 proteins containing mutations N9 and N10 exhibited apparent MWs that were smaller by approximately 2 kDa, suggesting that one or possibly both of these sites are utilized in the longer forms of the proteins. These results indicate that the length of the E2 protein can affect the utilization of N-linked sites 9 and 10 in this expression system both in BHK and Huh-7 cells. This may reflect differences in the availability of these sites for glycosylation in E2 660 vs. E2 715 and E2, or a requirement that these sites be glycosylated in the larger E2 715 and E2 proteins to facilitate folding of the additional carboxy-terminal segments.
Immunofluorescence analysis of E2 660 and N1-4, N5-8, and N1-8 mutants
The absence of N-linked carbohydrates on the E2 660 protein might be expected to impair or eliminate the integrity of its antibody epitopes as a result of loss of conformational stability. As an approach to this question, expression of the parental E2 660 protein and the N1 -N8 mutant was examined in Huh-7 cells using immunofluorescence (Fig. 8A) . In these experiments, the anti-polyhistidine antibody was used to detect the total amount of parental or mutant proteins expressed in the transfected cells, and a polyclonal goat antibody to E2 (recombinant E2, genotype 1a produced in CHO cells, [Virostat, Inc.] ) was used to monitor the presence of E2-specific epitopes. In separate experiments, these antisera were found to be reactive against E2 660 by immunoprecipitation under different detergent conditions (data not shown), but fluorescence was a more sensitive assay.
Both the parental E2 660 protein and the N1 -N8 mutant were readily detected in Huh-7 cells with anti-his antibody with a diffuse cytoplasmic staining pattern observed for these proteins (Fig. 8A) . Using the anti-E2 antibody, the parental E2 660 protein was detectable in essentially all of those cells positive by anti-his antibody, although the intensity of fluorescence varied somewhat from cell to cell. In contrast, antiserum to E2 was not able to detect the N1 -N8 mutant in any of the cells that were positive with anti-his antibody.
To determine if all of the N-linked glycans N1 to N8 were required for formation of E2 epitopes recognized by the anti-E2 antisera in this assay, the two mutant E2 660 proteins lacking either glycans N1 -N4 or N5 -N8 were then analyzed. Compared to the parental E2 660 protein, the N1-4 mutant exhibited a mildly reduced level of fluorescence, whereas the N5-8 mutant exhibited a markedly reduced fluorescence, but above the level produced by the N1-8 mutant (Fig. 8B) . The N1 -N4 and N5 -N8 mutant proteins were readily detectable with antisera to the polyhistidine tag, indicating that reduction in the levels of expression of these protein did not account for their diminished reactivity with the antisera to E2. These results suggest that N-linked glycans on E2 contribute to the integrity of antibody epitopes on this protein.
Discussion
In this study, expression of HCV E2 glycoproteins in transiently transfected cells was used to determine the utilization of its potential N-linked glycosylation sites and assess the importance of these glycans for processing and maturation of E2 in the secretory compartment. Based on the primary sequence of the E2 clone, 10 conserved potential N-linked sites were available, which is generally consistent with the structure of E2 based on comparisons of sequence data for different HCV isolates. Some isolates also contain a potential site at polyprotein position 476 -478, which can be utilized, and at position 532 -534 (Patel et al., 2000) . Similar to results of other studies which have examined the expression of E2, we observed that the fulllength form of E2 (E2) was retained in the cell, whereas truncated forms (E2 660 and E2 715 ) were recoverable both as cell-associated and secreted forms, with the E2 660 protein undergoing more efficient secretion from the cell than E2 715 . The core glycosylation of the E2 protein was membrane-dependent, required an amino-terminal signal sequence, and involved addition of approximately 20 kDa of carbohydrate, consistent with glycosylation at as many as 8 -10 N-linked sites. Studies of N-linked glycans on cellassociated forms of E2 have shown that they are sensitive to endoglycosidase H digestion and therefore not modified into complex carbohydrates (Dubuisson et al., 1994; Lanford et al., 1993) . Consistent with this, we observed that the E2 660 , E2 715 , and E2 proteins in BHK cells were sensitive to this enzyme. The failure to detect endoglycosidae H-resistant forms of E2 660 and E2 715 despite the presence of such forms in the media may indicate that intracellular levels of the resistant forms are very low due to inefficient modification in the Golgi compartment or rapid secretion after acquisition of complex carbohydrates. In any case, the data indicate that the E2 proteins we engineered for this study exhibited expected features based on current studies in the literature.
The E2 660 protein was initially used to characterize the utilization of N-linked sites in our experiments because efficient secretion of this truncated form from the cell allows an indirect assessment of the integrity of its folding (Michalak et al., 1997) . Mutagenesis of the 10 potential N-linked glycosylation sites on this protein revealed that each of the first eight predicted sites was implicated in the addition of an oligosaccharide chain. This is consistent with previous studies demonstrating that the E2 protein expressed by itself is a heavily glycosylated protein (Dubuisson et al., 1994; Lanford et al., 1993) . The utilization of N-linked sites 9 and 10 was not observed for the E2 660 protein, but at least one of these sites was modified in the context of E2 715 and E2. This may reflect a lack of accessibility of these N-linked sites in the E2 660 protein to the ER-associated oligosaccharide transferase as a result of effects conferred by the truncated carboxy terminus. Alternatively, there could be an inhibitory effect of the c-myc and polyhistidine epitope tags on glycosylation at these sites, although these tags did not appear to interfere with glycosylation of the E2 715 and E2 proteins at positions N9 or N10. In terms of effects of Nlinked glycosylation sites on E2 expression and processing, elimination of single or multiple sites had no obvious effect on the level of intracellular E2 protein produced, but did have noticeable effects on the capacity of the protein to be transported through the secretory pathway. Proteins containing single mutations were all recoverable from the media, but the levels were mildly reduced compared to that of the E2 660 parental protein. The decrease in secretion did not appear to vary as a function of which individual N-linked site was eliminated. Proteins lacking two or three N-linked glycans exhibited markedly reduced secretion from the cells, and proteins lacking four or more glycans failed to be secreted. Because the ability to traverse the secretory pathway implies formation of a properly folded glycoprotein (Ellgaard and Helenius, 2003; Ellgaard et al., 1999) , these data suggest that the loss of even a single N-linked glycan at positions 1 through 8 has a deleterious effect on the folding and maturation of E2 660 . Because no single mutation was able to abolish secretion, there may be no dominant effect of any one of the N-linked glycans on the folding process of E2 660 in this system, similar to results observed in various studies of other multiply glycosylated viral membrane glycoproteins such as the hemagglutinin protein of some subtypes of influenza (Gallagher et al., 1992 ; reviewed in Doms et al., 1993) . However, additional studies with more sensitive assays of the folding and function of the HCV E2 protein may yet reveal effects of individual N-linked glycosylation sites on its properties. Combinations of two Nlinked site mutations consistently reduced the secretion of E2 660 to low levels. This suggests additive or synergistic contributions of glycans towards the folding and transport of E2, at least for those combinations tested (N1 + N2, N1 + N3, N5 + N6, or N7 + N8). However, it is possible that other combinations of two mutations might actually abolish the transport and secretion of E2 660 .
The data presented here must be interpreted with caution in terms of implications about the importance of glycosylation for folding of the E2 protein. The properties of E2 expressed as a single protein are different from those of E2 incorporated into E1 -E2 complexes. This may include differences in conformational epitopes that are influenced by the interaction of E2 with E1, and which might exist only on the native infectious form of the virus (Clayton et al., 2002; Owsianka et al., 2001; Triyatni et al., 2002; Weiner et al., 2000) . In addition, truncated forms of E2 which lack the transmembrane region are incompetent for the formation of noncovalently bound E1 -E2 complexes, presumably because of the role of the transmembrane regions in the proper folding of E1 and E2, and possibly because of perturbations of ectodomain interactions which may influence association of these proteins. The data we have generated on N-linked glycosylation are therefore not necessarily reflective of events involved in HCV virion assembly, because this process involves budding of E1 -E2 complexes containing full-length proteins into the ER lumen. However, our findings may reflect to some extent the requirements for N-linked glycans during early folding events of E2 in the ER, which are dependent on interactions with chaperones specific for proteins bearing partially glucosylated N-linked oligosaccharides, and therefore may be important in the formation of some conformational antibody epitopes.
In a structural model for E2 based on homology modeling with the flavivirus tick-born encephalitis virus (TBEV) envelope protein, the positions of the 11 potential N-linked glycan sites on this molecule were predicted (Yagnik et al., 2000) . The data from our study are largely in agreement with these predictions, because we observed that glycosylation occurs at sites N1, N2, N3, N4, N5, N7, and N8, which correspond to polyprotein residues 417 -419, 423 -425, 430-432, 448-450, 532-534, 556 -558, and 576-578, respectively, in the model. However, the model predicted that sites N2 and N6 (polyprotein positions 423 -425 and 540 -542) were buried, whereas we provide evidence to indicate that these sites are in fact utilized for glycosylation. Discrepancies with the model for sites N2 and N6 may reflect the inability of the model to accurately predict the local structure of E2 in these regions due to low overall homology with the TBEV envelope protein upon which the model is based. Sites N9 and N10 correspond to polyprotein positions 623-625, which is predicted to be very exposed, and 645-647, which is predicted to be mostly buried in the model. Because we could not distinguish which of these two sites is utilized in the E2 715 and E2 proteins, conclusions about these positions cannot be made at this time. However, the model suggests that site N9 is most likely the site which is utilized.
A number of studies have analyzed the properties of truncated and full-length E2 proteins for their antigenic features and capacity to bind to the CD81 molecule (Chan-Fook et al., 2000; Clayton et al., 2002; Flint et al., 1999a Flint et al., , 1999b Flint et al., , 2000 Hadlock et al., 2000; Owsianka et al., 2001; Petracca et al., 2000; Wunschmann et al., 2000) . It has been shown that truncated forms such as E2 660 differ from full-length E2 and E2 produced in association with E1 in the context of virus-like particles or even virion particles, with respect to many features. These include reactivity with conformation-sensitive monoclonal antibodies (Clayton et al., 2002) , ability to bind either to the large extracellular loop of CD81 or to intact cells expressing this protein (Triyatni et al., 2002; Wunschmann et al., 2000) , and to be inhibited from binding to CD81 (Owsianka et al., 2001 ). Moreover, cell-associated E2 661 differs antigenically from the secreted form and is less able to bind CD81, in part as a result of differences in the processing of N-linked carbohydrates (Flint et al., 2000) . The factors that govern the different behavior of the various forms of E2 in these experiments are not well understood. Variations in primary structure can clearly affect the antigenic and functional properties of E2 (Patel et al., 2000) , but utilization of Nlinked glycans and their modification into high mannose and complex forms may also contribute. Our data indicate that truncated and full-length forms of E2 differ in their utilization of N-linked sites 9 or 10 (residues 623 -625 and 645-647, respectively), which lie in a region of E2 implicated in the formation of high molecular weight aggregates, and therefore indirectly in inhibition of E2 binding to CD81 (Flint et al., 2000; Patel et al., 2000) . The possibility exists that lack of these glycans on the truncated E2 660 protein is in part responsible for structural differences that distinguish this protein from full-length E2 in the various receptor binding assays. In some cases, the absence of N-linked glycans on a glycoprotein can affect processing of oligosaccharides on adjacent glycans, which might affect its functional properties (Roberts et al., 1993) . N-linked glycosylation has an important role in the folding and maturation of viral envelope proteins by promoting the proper formation of their ectodomains during entry into the ER lumenal environment. The acquisition of N-linked glycans confers the capacity to interact with ER chaperones which are involved in regulating the exit of nascent proteins from the ER. These interactions require the presence of partially glucosylated oligosaccharides which are trimmed and reglucosylated by UDP-glucose/glycoprotein glucosyltransferase during cycling of incompletely folded proteins within the ER. In this respect, some glycoproteins are critically dependent on the presence of single glycans to enable this process. The complicated nature of E1 -E2 complex formation, with its long halftime of formation, and the intricate nature of protein -protein interactions required for proper formation of the E1 -E2 complex support the notion that multiple N-linked glycosylation events would have an important functional role. However, the limited effects of single mutations on the secretion of the E2 660 protein suggest that individual glycans have minor effects on the folding of E2. In this sense, we suggest that the function of multiple N-linked glycans may be to contribute locally to the conformational stability of E2, which is slowly driven by prolonged interactions with the ER chaperones. This has also been suggested for other viral glycoproteins (Gallagher et al., 1992; Roberts et al., 1993) . Further experiments to examine the interactions of N-linked E2 mutants with these chaperones are needed to substantiate this hypothesis. Additional studies are also needed to determine if the effects we have observed for N-linked glycans on E2 660 are similar to effects on the assembly of native E1 -E2 complexes. Other functions of multiple glycans may include effects on reducing accessibility of antibody to epitopes on the virion surface, as well as affecting the interaction of HCV particles with cell-surface molecules during the process of virus entry. Studies of engineered HCV-like particles lacking specific N-linked glycans in in vitro systems of neutralization and binding to cellular receptors may yield insights into the existence such additional functions.
The E2 660 protein could be readily detected by immunofluorescence in Huh-7 cells using antisera to recombinant E2. It is not known if the epitopes detected with these antisera represent native E2 epitopes, and further experiments with conformation-sensitive monoclonal antibodies are needed to assess the antigenic integrity of E2 660 and its N-linked glycan mutants. However, the lack of reactivity of the antisera with the unglycosylated N1 -N8 mutant and reduced reactivity with the partially glycosylated forms N1 -N4 and N5 -N8 indicate that the N-linked glycans appear to be required for the formation of some antibody epitopes on E2 660 . This is presumably related to the role of these residues in facilitating the interactions of E2 protein with the ER chaperones required for proper folding of the nascent protein, and suggests that multiple N-linked glycans are necessary for acquisition of the epitopes. Further studies are needed to determine how dependent the formation of the antigenic structure of properly folded E1 -E2 native complexes is on the presence of multiple glycans, particularly if they are required for maintaining the antigenic structure of these complexes after they are properly assembled. Such information may have implications for the design of subunit vaccine modalities for eliciting antibodies against HCV based on expression of E1 -E2 complexes.
Materials and methods
Cells and viruses
BHK-21 cells were obtained from the ATCC and grown in minimal essential medium containing 10% fetal bovine serum and penicillin-streptomycin. Huh-7 cells were provided by Dr. John Tavis (Saint Louis University) and grown in 50:50 Dulbecco's minimal essential medium (DMEM; Life Technologies) and F12 supplemented with 10% fetal bovine serum. A vaccinia virus recombinant expressing the T7 DNA polymerase, vTF7-3, was used for transient expression assays. This virus was used as described previously (Chambers et al., 1993) .
Plasmid constructions
A pBluescript II plasmid (Stratagene) containing a 1700-base pair fragment consisting of the E1/E2 region was initially constructed. The cDNA for the E1 -E2 region was derived by RT -PCR using RNA prepared from a serum specimen of a patient chronically infected with a 1a genotype virus. The RT reaction was done using a primer corresponding to nucleotides 2641 -2665 in the presence of Superscript II (Gibco). First round PCR was done with primers corresponding to nucleotides 819 -841 and 2631-266, and second round PCR was done using primers corresponding to nucleotides 852 -873 and 2530 -2551, containing EcoRI and HindIII restriction sites. The PCR product was purified using a Quiagen Spin Kit, digested with EcoRI and HindIII, and cloned into pBluescript-KS(II) after digestion with the same enzymes. The resulting clones were verified by nucleotide sequencing and used for further constructions. The sequence has been submitted to GenBank (accession number AY388455). The E2 region with its corresponding signal sequence was amplified by PCR using Deep Vent DNA polymerase (New England Biolabs) and a combination of primers to create constructs containing the Cterminal signal sequence of E1 (sig) and an E2 open reading frame of varying lengths (Fig. 1) . SigE2 660 is a truncated version of E2 that ends at amino acid 276 within the E2 protein. SigE2 715 ends at amino acid 331, and sigE2 contains the E2 reading frame up to residue 362. Each PCR product was subcloned into the pCR-Blunt-TOPO plasmid vector (Invitrogen) and subsequently inserted into pcDNA3.1/mycHis(-) using NheI and KpnI restriction sites. All expression constructs contained the c-myc and polyhistidine epitopes immediately downstream of the carboxy termini to facilitate identification of proteins by immunoprecipitation or immunofluorescence. All final plasmid constructs were verified by nucleotide sequencing.
Site-directed mutagenesis
Single glycosylation site mutants were created using the QuikChange Site-Directed Mutagenesis Kit (Stratagene). Synthetic oligonucleotide primers were designed to replace the Ser or Thr of the N-linked acceptor site (Asn-X-Thr/Ser where X is any amino acid except Pro) with an Ala residue. The mutants are designated by N1, N2, N3, etc. (N for the Asn modification and the number of the glycosylation site in the E2 protein). Multiple site mutants were generated by sequential rounds of site-directed mutagenesis or by subcloning fragments from plasmids containing the engineered mutations using available restriction sites in the E2 region. The plasmids used for mutagenesis of the N-linked sites were as follows. N1, 5V -GTAAACAG-
Cell-free translation
Translation was performed using the TNT system (Promega). Reactions were programmed with 1 Ag of plasmid DNA in 25-Al volumes in the presence of components as recommended by the manufacturer, including 1.5 Al of canine pancreatic microsomal membranes and 35 [S]-methionine (Amersham) at 10 ACi/reaction. Control reactions for membrane-dependent core-glycosylation and signal peptide processing were run using reagents supplied by the manufacturer. Translation was carried out at 30 jC for 90 min, following which samples were solubilized in an equal volume of 2 Â Laemmli sample buffer by heating at 70 jC for 30 min. Translation products were analyzed on 12% SDS polyacrylamide gels.
Transient expression assay
BHK-21 cells grown to 90 -95% confluency in 35-mm dishes were infected with vTF7-3 at a multiplicity of approximately 10 PFU per cell. After 30 min, the inoculum was removed, the cells were washed, and 1 ml of minimal essential medium containing 1 Ag plasmid DNA, 4 Al of lipofectamine, and 6 Al of PLUS (Life Technologies) was added, and the cells were incubated at 37 jC for 2.5 h. The transfection mixture was removed, the cells washed, and minimal essential medium containing 1/40th the normal concentration of methionine, 5% fetal bovine serum, and 35 [S]-methionine label (40 microCi/ml) was added for 5 h. Lysates and supernatants were then prepared for immunoprecipitation. For transient expression assays in Huh-7 cells, cells were grown to 80% confluency and infected with vTF7-3 as described above. DMEM/F12 (1 ml) containing 2 Ag DNA and 20 Al lipofectin (Life Technologies) was added and the cells were incubated for 2 -2.5 h. Cells were then labeled as described previously. E2 expression was examined in cell extracts and media as described below.
Immunoprecipitation and gel electrophoresis
Labeled cells were lysed with 1% sodium dodecyl sulfate (SDS) in 0.1 M Tris (pH 7.5), 0.3 M NaCl, and 2 mM EDTA containing 20 Ag/ml of phenylmethylsulfonyl fluoride. Lysates were sheared through a 26-gauge syringe, heated at 70 jC for 10 min, and centrifuged at 14,000 RPM for 5 min in an eppendorf microcentrifuge. Supernatants were collected, diluted 1:1 with 2Â TNA (1% Triton X-100, 0.1 M Tris pH 7.5, 2 mg/ml BSA, and 2 mM EDTA), then diluted 1:1 with 1Â TNA, and 2 Al each of anti-c-myc and anti-his antibodies (Invitrogen) were added. Reactions were incubated for 12 h at 4 jC on a shaker and the immune complexes were collected using Staphylococcus aureus Cowan strain I (Calbiochem). Immunoprecipitates were washed three times with 1Â TNA containing 125% SDS followed by TNE (50 mM Tris pH 7.5, 1 M NaCl, and 1 mM EDTA). Proteins were recovered from the media by adding Triton and SDS to final concentrations of 0.1% and 0.2%, respectively, and then anti-c-myc and anti-his antibodies were added. Immune complexes were collected as above but washed with 1Â TNA and TNE containing 150 mM NaCl. Immunoprecipitates were solubilized in Laemmli sample buffer, run on SDS-polyacrylamide gel electrophoresis, and proteins were detected by autoradiography.
Endoglycosidase digestions
PNGase F and Endo H digestions were performed according to the manufacturer's protocols (New England Biolabs). Cells were transfected and immunoprecipitated as described above. The pellets were denatured in 1Â glycoprotein denaturing buffer (5% SDS, 10% h-mercaptoethanol) at 100 jC for 10 min. The samples were centrifuged at 10,000 rpm for 1 min in an Eppendorf microcentrifuge, and the supernatants were transferred to new tubes. For PNGase F digestion, 10Â G7 Buffer (0.5 M sodium phosphate pH 7.5 at 25 jC) and 10% NP-40 were each added at 1/10 the volume of sample. PNGase F (1 Al) was then added and the reaction was incubated at 37 jC for 1 h. The samples were then aliquoted into two tubes and each diluted 1:1 with 2% SDS sample buffer. For Endo H digestion, samples were denatured as described and 1/10 the volume of 10Â G5 Buffer (0.5 M sodium citrate pH 5.5 at 25 jC) was added. Endoglycosidase H (1 Al) was added and the reaction was incubated at 37 jC for 1 h. Samples were aliquoted and diluted as described for endoglycosidase F.
Immunofluorescence
Subconfluent monolayers of Huh-7 cells were transfected as described above and processed by fixation in 4% paraformaldehyde for 15 min, followed by permeabilization with methanol at À20 jC for 5 min. Primary antibodies (mouse monoclonal anti-his and anti-c-myc [Invitrogen] , or goat anti-recombinant E2 [Virostat]) were incubated with the cells at dilutions of 1:1000 or 1:200, respectively. Secondary antibodies (FITC-labelled rabbit anti-mouse or rabbit anti-goat [ICN Pharmaceuticals]) were used at dilutions of 1:500 or 1:250. Cells were analyzed by fluorescence microscopy and photographed with a SPOT camera (Diagnostic Instruments).
